Patient | Demographic | Duration of untreated pulmonary sarcoidosis | Presenting/additional cardiac complaint | Cardiac sarcoidosis treatment to date | Response to treatment |
---|---|---|---|---|---|
Patient 1 | 50 M | 2 years | Dilated cardiomyopathy, CCF with LVEF 10–15%, non-sustained VT/AF | Prednisone Methotrexate | Improved LVEF to 53%. Complete resolution of cardiomegaly and FDG uptake on PET |
Patient 2 | 37 F | 2 years | CHB/Mobitz type II heart block | Prednisone Methotrexate PPM/AICD | Nil further cardiac events. Resolution of FDG uptake on PET |